Delivery Order SPE2DB22D9130-SPE2DB25FE0DN

Award Date 4/8/25
Potential Completion Date 4/29/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The $5,868.00 contract is for the delivery of the contraceptive device KYLEENA 19.5 MG SYSTEMS to support the recurring medical supply needs of military health facilities. The contract has an ultimate completion date of October 9, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,203.86 contract is for the delivery of 4566759551 - KYLEENA 19.5 MG SYSTEMS, a specialized pharmaceutical product, with a completion date of January 2, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,478.76 contract is for the delivery of KYLEENA 19.5 MG SYSTEMS, which are contraceptive implants, with a performance period ending on August 1, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the agency to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $5,859.20 contract is for the delivery of Kyleena 19.5 MG Systems, a contraceptive device, with a period of performance through September 6, 2023. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,757.76 contract is for the delivery of the contraceptive device KYLEENA 19.5 MG SYSTEMS and has an ultimate completion date of January 5, 2024. DMS Pharmaceutical Group Inc. also holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of KYLEENA 19.5 MG SYSTEMS, a contraceptive device, with a ceiling value of $2,478.76 and a completion date of July 1, 2025. DMS Pharmaceutical Group Inc. is an established pharmaceutical wholesaler that has secured a significant single-award Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $6,196.90 contract is for the delivery of KYLEENA 19.5 MG SYSTEMS, a pharmaceutical product. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,098.45 contract is for the delivery of 4566976277 - KYLEENA 19.5 MG SYSTEMS, a pharmaceutical product, with a period of performance through February 5, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of KYLEENA 19.5 MG SYSTEMS, a type of pharmaceutical product, with an ultimate completion date of April 16, 2024, and a ceiling value of $15,048.00. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the...
This firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) on December 13, 2023. The contract has a ceiling value of $3,515.52 and an ultimate completion date of January 5, 2024. The contract covers the supply of KYLEENA 19.5 MG SYSTEMS, a contraceptive device, to fulfill the recurring medical supply needs of military health facilities worldwide. This award is part of DMS...
  • SPE2DB22D9130
    Indefinite Delivery Contract
  • SPE2DB22D9130-SPE2DB25FE0DN
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,478.76 contract is for the delivery of the pharmaceutical product KYLEENA 19.5 MG SYSTEMS, which is a contraceptive device. The contract has an ultimate completion date of April 29, 2025.

DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This specific delivery order is not associated with any set-aside designation.

Generated 7/8/25, 2:18 PM